AMRI to Present at Two Investor Conferences

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) announced today that it will present and provide an audio webcast of its corporate presentations at the following investor conferences.

AMRI Chairman, President and Chief Executive Officer Thomas E. D'Ambra, Ph.D. will present at the UBS 2008 Global Healthcare Services Conference on Tuesday, February 12^th at 1:30 p.m. Eastern Standard Time at the Grand Hyatt Hotel, New York City.

AMRI Director of Investor Relations, Peter Jerome, will present at the 10^th Annual BIO CEO & Investor Conference on Tuesday, February 12^th at 3:30 p.m. Eastern Standard Time at the Waldorf-Astoria Hotel, New York City.

Both audio webcasts will be available to investors and interested parties by accessing the company’s website at www.amriglobal.com . In addition, replays of the webcasts will be available after the live webcast through March 31, 2008.

Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.